Drug Trial Radar · NCT00198445
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
Last checked: Nov 20, 2026Latest source record: Mar 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
527
Actual
Start
May 2003
Primary completion
Jan 2004
Study completion Jan 2004
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study was to investigate the efficacy of bromfenac sodium ophthalmic solution 0.09% for treatment of post-operative ocular inflammation in subjects who undergo cataract extraction and intraocular lens implantation. The secondary objective was to investigate the safety and tolerability of the same.
Conditions
- Postoperative Complications
- Cataract
Interventions
BromfenacDrug
One drop in study eye every 12 hours for 14 days
PlaceboDrug
One drop in study eye every 12 hours for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Inflammation ScoreTime frame: Visit 4 (Day 15)
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Harold A Helms, MD
Birmingham, Alabama
Eye Care Arkansas, PA
Little Rock, Arkansas
UCI, Department of Ophthalmology
Irvine, California
Anesthetic Eye Care Institute
Newport Beach, California
Richard A Lewis, MD
Sacramento, California
Eye Care of San Diego
San Diego, California
Santa Clara Valley Medical Center
San Jose, California
E Randy Craven, MD
Littleton, Colorado
The Eye Care Group
New Haven, Connecticut
Cohen Laser Vision Center
Boca Raton, Florida
Brandon Cataract Center & Eye Clinic
Brandon, Florida
Marvin E Greenberg, MD, PA
Tamarac, Florida
Jack Daubert, MD
West Palm Beach, Florida
Advanced Eye Care, PC
Fort Oglethorpe, Georgia
Saltzer Medical Group, PA
Nampa, Idaho
Donald E Beahm, MD
Great Bend, Kansas
Cincinnati Eye Institute NKY
Edgewood, Kentucky
Tulane University Health Sciences Center
New Orleans, Louisiana
Stevenson Medical Surgical Eye Center
New Orleans, Louisiana
Cornea Consultants
Boston, Massachusetts
Great Lakes Eye Care
Saint Joseph, Michigan
Hunkeler Eye Institute
Kansas City, Missouri
Arthur J Weinstein, MD
Albuquerque, New Mexico
Ophthalmic Consultants of Long Island
Rockville Centre, New York
Horizon Eye Care
Charlotte, North Carolina
Dean A McGee Eye Institute
Oklahoma City, Oklahoma
The Eye Institute
Tulsa, Oklahoma
Casey Eye Institute
Portland, Oregon
Eye Health Northwest
Portland, Oregon
Scheie Eye Institute
Philadelphia, Pennsylvania
Black Hills Regional Eye Institute
Rapid City, South Dakota
Middle Tennessee Eye Associates
Cookeville, Tennessee
Texan Eye Care PA
Austin, Texas
Ophthalmology Service, Brooke Army Medical Center
Fort Sam Houston, Texas
Ophthalmology Visual Science
Galveston, Texas
Houston Eye Associates
Houston, Texas
David G Shulman, MD
San Antonio, Texas
Central Texas Eye Center
San Marcos, Texas
Virginia Eye Consultants
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.